---
title: "Meditation Practice and Long-Term Mortality in US Adults: Pooled NHIS Cohorts Analysis"
id: "medrxiv-6-meditation-practice-and-long-term-mortality-in-us-adults-a-doubly-robust"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-6-meditation-practice-and-long-term-mortality-in-us-adults-a-doubly-robust"
content_type: "clinical_feed_article"
specialty: "General"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.17.26363306v1?rss=1"
published_at: "2026-09-20T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Meditation Practice and Long-Term Mortality in US Adults: Pooled NHIS Cohorts Analysis
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-6-meditation-practice-and-long-term-mortality-in-us-adults-a-doubly-robust
- **Specialty:** [General](https://medichelpline.com/clinical-feed/general.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.17.26363306v1?rss=1)
- **Published At:** 2026-09-20T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This pooled analysis used four National Health Interview Survey (NHIS) cohorts from 2002–2017 with mortality follow-up through 2019, totaling 90,041 adults and 818,248 person-years of observation. 8,402 (9.3%) reported meditation practice in the prior 12 months. - The study combined stabilized inverse-probability weights with covariate adjustment in **doubly robust** survey-weighted Cox models to estimate associations between **meditation** and mortality, and standardized 15-year risks via g-computation. - Over follow-up there were 10,027 all-cause deaths and 3,040 cardiovascular deaths. Doubly robust hazard ratios were 1.02 (95% CI 0.90–1.16) for all-cause mortality and 0.96 (95% CI 0.79–1.16) for cardiovascular mortality, indicating no overall association after adjustment. - Income-stratified estimates suggested potential protective associations among adults below 200% of the federal poverty level: HR 0.85 (all-cause; 95% CI 0.71–1.03) and HR 0.80 (cardiovascular; 95% CI 0.57–1.10). For those at/above 200% FPL, HRs were 1.10 (all-cause; 95% CI 0.93–1.30) and 1.02 (cardiovascular; 95% CI 0.80–1.30). Interaction p-values were 0.19 and 0.62, respectively. - Probabilistic bias analysis addressed exposure misclassification, including stratified scenarios by income, but specific bias-adjusted estimates were not detailed in the abstract. - For a high-risk subgroup—non-Hispanic Black adults aged ≥55 years with hypertension (n=2,786)—the authors performed a Bayesian synthesis combining subgroup estimates with a pooled randomized trial prior. Using a 50%-discounted trial prior, posterior estimates were 0.84 for all-cause mortality (Pr[HR<1]=0.89) and 0.70 for cardiovascular mortality (Pr[HR<1]=0.96), suggesting probable cardiovascular benefit in that trial-comparable subgroup. - The authors conclude no overall association between **meditation** practice and mortality after doubly robust adjustment, but highlight hypothesis-generating signals of benefit concentrated among lower-income adults and probable cardiovascular benefit in a high-risk trial-comparable subgroup, calling for further study with more detailed exposure measurement. - All data used are publicly available via the National Center for Health Statistics linked mortality files. The authors reported no competing interests.
## Clinical Analysis & Structured Key Points
Meditation Practice and Long-Term Mortality in US Adults: A Doubly Robust Analysis of Pooled National Health Interview Survey Cohorts with a Trial-Informed Bayesian Subgroup Analysis | medRxiv Skip to main content Meditation Practice and Long-Term Mortality in US Adults: A Doubly Robust Analysis of Pooled National Health Interview Survey Cohorts with a Trial-Informed Bayesian Subgroup Analysis Lu Shi , Yian Gu , Hafsa Imtiaz , View ORCID Profile Donglan Zhang , Anthony D. Mancini doi: https://doi.org/10.64898/2026.09.17.26363306 Lu Shi 1 Department of Health Science, College of Health Professions, Pace University, New York, NY; Find this author on Google Scholar Find this author on PubMed Search for this author on this site For correspondence: lshi{at}pace.edu Yian Gu 2 Departments of Neurology and Epidemiology, Gertrude H. Sergievsky Center, and Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, NY; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Hafsa Imtiaz 1 Department of Health Science, College of Health Professions, Pace University, New York, NY; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Donglan Zhang 3 Division of Health Services Research, Department of Foundations of Medicine, NYU Grossman Long Island School of Medicine, New York, NY; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Donglan Zhang Anthony D. Mancini 4 Department of Psychology, Pace University, Pleasantville, NY Find this author on Google Scholar Find this author on PubMed Search for this author on this site Abstract Info/History Metrics Data/Code Preview PDF Abstract ABSTRACT Introduction: Trial evidence in older adults with hypertension suggests that meditation may lower mortality, but this association has not been tested in a nationally representative study with linked-mortality data. This study estimated meditation's association with mortality among US adults, examined variation by family income, and synthesized trial and survey evidence for the population matched to the trial evidence base. Methods: We pooled four National Health Interview Survey cohorts (2002 to 2017) with mortality follow-up through 2019 (N=90,041; 8,402 [9.3%] reported meditation practice in the past 12 months). Doubly robust survey-weighted Cox models combined stabilized inverse-probability weights with covariate adjustment, overall and by income stratum; 15 year risks were standardized using g computation, and probabilistic bias analysis addressed exposure misclassification, including a scenario by income strata. For non Hispanic Black adults ≥55 years with hypertension (n=2,786), Bayesian synthesis combined subgroup estimates with a pooled randomized trial prior. Results: Over 818,248 person years of follow up, 10,027 all cause and 3,040 cardiovascular deaths occurred. Doubly robust hazard ratios (HR) were 1.02 (95% CI 0.90, 1.16) for all cause and 0.96 (95% CI 0.79, 1.16) for cardiovascular mortality. Among individuals below 200% of the federal poverty level, HRs were 0.85 (All cause: 95% CI 0.71, 1.03) and 0.80 (Cardiovascular mortality: 95% CI 0.57, 1.10), compared with 1.10 (95% CI 0.93, 1.30) and 1.02 (95% CI 0.80, 1.30) among those at/above that threshold (interaction p=0.19 and p=0.62). In the subgroup analysis, posteriors under a 50%-discounted trial prior were 0.84 (All-cause mortality: Pr[HR<1]=0.89) and 0.70 (Cardiovascular mortality: Pr[HR<1]=0.96). Conclusions: Meditation practice showed no overall association with mortality after doubly robust adjustment. However, estimates suggesting a protective effect were concentrated among adults below 200% of the federal poverty level, and trial-informed synthesis indicated probable benefit in cardiovascular mortality in the high-risk subgroup most comparable to trial participants. These hypothesis-generating findings motivate further study of effect modification using more detailed exposure measurement. Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The study used (or will use) ONLY openly available human data that were originally located at National Center of Health Statistics. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability All data used are available online at National Center for Health Statistics https://www.cdc.gov/nchs/linked-data/mortality-files/index.html https://www.cdc.gov/nchs/linked-data/mortality-files/index.html Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Back to top Previous Next Posted September 20, 2026. Download PDF Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Meditation Practice and Long-Term Mortality in US Adults: A Doubly Robust Analysis of Pooled National Health Interview Survey Cohorts with a Trial-Informed Bayesian Subgroup Analysis Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Meditation Practice and Long-Term Mortality in US Adults: A Doubly Robust Analysis of Pooled National Health Interview Survey Cohorts with a Trial-Informed Bayesian Subgroup Analysis Lu Shi , Yian Gu , Hafsa Imtiaz , Donglan Zhang , Anthony D. Mancini medRxiv 2026.09.17.26363306; doi: https://doi.org/10.64898/2026.09.17.26363306 Share This Article: Copy Citation Tools Meditation Practice and Long-Term Mortality in US Adults: A Doubly Robust Analysis of Pooled National Health Interview Survey Cohorts with a Trial-Informed Bayesian Subgroup Analysis Lu Shi , Yian Gu , Hafsa Imtiaz , Donglan Zhang , Anthony D. Mancini medRxiv 2026.09.17.26363306; doi: https://doi.org/10.64898/2026.09.17.26363306 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Area Public and Global Health Subject Areas All Articles Addiction Medicine (619) Allergy and Immunology (903) Anesthesia (334) Cardiovascular Medicine (4825) Dentistry and Oral Medicine (479) Dermatology (418) Emergency Medicine (651) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1633) Epidemiology (15970) Forensic Medicine (33) Gastroenterology (1206) Genetic and Genomic Medicine (7060) Geriatric Medicine (734) Health Economics (1066) Health Informatics (5058) Health Policy (1436) Health Systems and Quality Improvement (1775) Hematology (587) HIV/AIDS (1347) Infectious Diseases (except HIV/AIDS) (16302) Intensive Care and Critical Care Medicine (1174) Medical Education (671) Medical Ethics (155) Nephrology (727) Neurology (7290) Nursing (368) Nutrition (1084) Obstetrics and Gynecology (1243) Occupational and Environmental Health (1005) Oncology (3613) Ophthalmology (1055) Orthopedics (398) Otolaryngology (457) Pain Medicine (472) Palliative Medicine (139) Pathology (709) Pediatrics (1805) Pharmacology and Therapeutics (739) Primary Care Research (768) Psychiatry and Clinical Psychology (5916) Public and Global Health (9769) Radiology and Imaging (2431) Rehabilitation Medicine and Physical Therapy (1456) Respiratory Medicine (1249) Rheumatology (642) Sexual and Reproductive Health (773) Sports Medicine (579) Surgery (781) Toxicology (107) Transplantation (305) Urology (293)
## Related Clinical Research

- [NIH expands eligibility so businesses and nontraditional entities can apply for facilities funding](https://medichelpline.com/clinical-feed/stat-news-4-businesses-can-now-apply-for-nih-funding.md)
- [Antihypertensive Drug Class and Risk of Incident Alzheimer’s Disease and Related Dementias: Replic](https://medichelpline.com/clinical-feed/medrxiv-17-antihypertensive-medication-class-and-incident-alzheimers-disease-and-related.md)
- [Pathway-specific polygenic risk scores identify biological mechanisms of cerebral small vessel dis](https://medichelpline.com/clinical-feed/medrxiv-21-pathway-specific-polygenic-risk-scores-reveal-underlying-mechanisms-of-cerebral.md)
- [Tanshinone IIA improves cognition in vascular dementia rats by modulating copper homeostasis](https://medichelpline.com/clinical-feed/plos-one-5-tanshinone-iia-attenuates-cognitive-impairment-in-vascular-dementia-rats-by.md)
- [Impact of Nighttime Light Exposure on Heart Health and Disease Risk](https://medichelpline.com/clinical-feed/medical-news-today-0-nighttime-light-exposure-may-alter-the-heart-and-increase-disease-risk.md)

## Navigation
- [← Back to General Feed](https://medichelpline.com/clinical-feed/general.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.